This is the list of the largest public listed companies in the Healthcare sector from the United States by market capitalization with links to their reference stock and industry.
Company Profile:
XOMA Corporation
Market Cap (USD):
$322.6 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Atea Pharmaceuticals, Inc.
Market Cap (USD):
$320.1 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Annexon, Inc.
Market Cap (USD):
$317.1 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Olema Pharmaceuticals, Inc.
Market Cap (USD):
$312.7 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Rocket Pharmaceuticals, Inc.
Market Cap (USD):
$312.4 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Nektar Therapeutics
Market Cap (USD):
$307.2 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Corvus Pharmaceuticals, Inc.
Market Cap (USD):
$304.6 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Abeona Therapeutics Inc.
Market Cap (USD):
$301.3 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Oyster Point Pharma, Inc.
Market Cap (USD):
$299.9 M
(Dec. 1, 2022)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
SOC Telemed, Inc.
Market Cap (USD):
$295.7 M
(April 1, 2022)
Country:
United States
Sector:
US Healthcare
Industry:
US Medical Care Facilities
Company Profile:
Cerus Corporation
Market Cap (USD):
$294.4 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Vanda Pharmaceuticals Inc.
Market Cap (USD):
$292.9 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Alimera Sciences, Inc.
Market Cap (USD):
$290.8 M
(July 1, 2024)
Country:
United States
Sector:
US Healthcare
Industry:
US Drug Manufacturers—Specialty & Generic
Company Profile:
Foghorn Therapeutics Inc.
Market Cap (USD):
$286.0 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Cerecor Inc.
Market Cap (USD):
$285.0 M
(June 1, 2022)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Viemed Healthcare, Inc.
Market Cap (USD):
$282.6 M
Country:
United States
Sector:
US Healthcare
Industry:
US Medical Devices
Company Profile:
Health Catalyst, Inc.
Market Cap (USD):
$282.6 M
Country:
United States
Sector:
US Healthcare
Industry:
US Health Information Services
Company Profile:
Gossamer Bio, Inc.
Market Cap (USD):
$281.9 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Ocugen, Inc.
Market Cap (USD):
$279.5 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Frontage Holdings Corp
Market Cap (USD):
$278.4 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Quanterix Corporation
Market Cap (USD):
$271.2 M
Country:
United States
Sector:
US Healthcare
Industry:
US Medical Devices
Company Profile:
SmileDirectClub, Inc.
Market Cap (USD):
$270.7 M
(July 1, 2023)
Country:
United States
Sector:
US Healthcare
Industry:
US Medical Devices
Company Profile:
Avalon GloboCare Corp.
Market Cap (USD):
$265.9 M
Country:
United States
Sector:
US Healthcare
Industry:
US Medical Care Facilities
Company Profile:
Verastem, Inc.
Market Cap (USD):
$263.8 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Sanara MedTech Inc.
Market Cap (USD):
$263.5 M
Country:
United States
Sector:
US Healthcare
Industry:
US Medical Care Facilities
Company Profile:
Allogene Therapeutics, Inc.
Market Cap (USD):
$260.3 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Inozyme Pharma, Inc.
Market Cap (USD):
$258.2 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Aldeyra Therapeutics, Inc.
Market Cap (USD):
$257.6 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Chiasma, Inc.
Market Cap (USD):
$253.0 M
(July 1, 2021)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
OptimizeRx Corporation
Market Cap (USD):
$248.4 M
Country:
United States
Sector:
US Healthcare
Industry:
US Health Information Services